NCT06140524 · Interventional trial
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Overall registry status Recruiting
Phase 2
Conditions Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM)
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory